Format

Send to

Choose Destination
See comment in PubMed Commons below
Cell Stem Cell. 2010 Jun 4;6(6):517-20. doi: 10.1016/j.stem.2010.05.012.

Pharma's developing interest in stem cells.

Author information

  • 1Pfizer Regenerative Medicine, Cambridge, UK. ruth.mckernan@pfizer.com

Abstract

Human stem cell biology is driving the promise of novel regenerative therapies into clinical trials. Although the pharmaceutical industry has embraced stem cells as tools in drug discovery, few companies have taken the risk to deliver stem cell-based medicines. Here, we evaluate the various cell-based opportunities and corporate strategies.

PMID:
20569688
DOI:
10.1016/j.stem.2010.05.012
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center